LRN Form 4: EVP granted time- and performance-based equity awards
Rhea-AI Filing Summary
McMullen Greerson Greene, EVP and General Counsel of Stride, Inc. (LRN), acquired equity awards on 08/08/2025 consisting of 2,676 restricted shares and 1,004 restricted stock rights. The restricted shares vest semi-annually with 20% vesting in the first year and 40% vesting in each of the next two years. The restricted stock rights are performance-based and will vest only if certain compound annual growth rates in the company’s common stock price are achieved by 09/15/2028; the amount reported represents the threshold award.
The grants were made at a $0 price and are reported as directly beneficially owned following the transactions, with 13,426 shares of common stock held directly and 1,004 restricted stock rights outstanding. These awards combine time-based and performance-based vesting conditions for executive compensation.
Positive
- Grant of 2,676 restricted shares with a clear time-based vesting schedule (20% first year; 40% in each of the following two years).
- Grant of 1,004 performance-based restricted stock rights that vest only if specified compound annual growth rate targets in the company’s stock price are met by 09/15/2028.
Negative
- None.
Insights
TL;DR: Routine executive equity grants: time-based restricted shares and performance rights reported at $0, reflecting compensation, not a sale.
The filing shows an award of 2,676 restricted shares with a detailed 20%/40%/40% vesting schedule and 1,004 performance-contingent restricted stock rights tied to stock-price CAGR through 09/15/2028. Both awards are reported as directly beneficially owned and granted at no cash price ($0). From a securities perspective this is a standard compensation grant disclosed under Section 16 and signals management alignment via time and performance vesting rather than a liquidity event.
TL;DR: Compensation structure mixes time-based vesting and stock-price performance hurdles, aligning long-term incentives for the reporting executive.
The reported awards incorporate a time-based restricted share tranche (semi-annual vesting, 20% first year, then 40%/40%) and a performance-based tranche (restricted stock rights that vest only upon meeting specified compound annual growth rate targets by 09/15/2028). The filing identifies the recipient as the EVP and General Counsel and reports direct beneficial ownership after the grant. Governance-wise, the combination of time and performance conditions is a common design to tie executive rewards to multi-year outcomes.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Right | 1,004 | $0.00 | -- |
| Grant/Award | Common Stock | 2,676 | $0.00 | -- |
Footnotes (1)
- These shares are restricted and vest semi-annually, with 20% vesting in the first year and 40% vesting in each of the next two years following the grant date. Represents an award of restricted stock rights, each of which represents a contingent right to receive one share of the Company's common stock. The restricted stock rights will vest based on the achievement of certain compound annual growth rates in the price of the Company's common stock between the award date and September 15, 2028, subject to earlier vesting in certain circumstances described in the applicable award agreement. The amount reported herein represents the threshold amount under the award.
